Astrid Eliasen

Soborg, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes.

Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes.

Journal: The New England journal of medicine

Published: June 22, 2025

Feasibility of an Intravenous Home Chemotherapy Intervention With Low-Dose Cytarabine Administered by Parents (INTACTatHome).

Feasibility of an Intravenous Home Chemotherapy Intervention With Low-Dose Cytarabine Administered by Parents (INTACTatHome).

Journal: Pediatric blood & cancer

Published: March 23, 2025

Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants.

Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants.

Journal: Diabetes, obesity & metabolism

Published: July 30, 2024

Response to comment on "Risk factors associated with nausea and vomiting in children with cancer receiving chemotherapy".

Response to comment on "Risk factors associated with nausea and vomiting in children with cancer receiving chemotherapy".

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: January 31, 2023

Risk factors associated with nausea and vomiting in children with cancer receiving chemotherapy.

Risk factors associated with nausea and vomiting in children with cancer receiving chemotherapy.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: August 30, 2022

The efficacy and safety of proton pump inhibitors in infants with reflux

The efficacy and safety of proton pump inhibitors in infants with reflux

Journal: Ugeskrift for laeger

Published: April 12, 2022

Background sensitivity to chemotherapy-induced nausea and vomiting and response to antiemetics in paediatric patients: a genetic association study.

Background sensitivity to chemotherapy-induced nausea and vomiting and response to antiemetics in paediatric patients: a genetic association study.

Journal: Pharmacogenetics and genomics

Published: November 09, 2021

Safety of rapid intravenous paracetamol infusion in paediatric patients.

Safety of rapid intravenous paracetamol infusion in paediatric patients.

Journal: Current research in pharmacology and drug discovery

Published: July 08, 2021

Smartphone App to Self-Monitor Nausea During Pediatric Chemotherapy Treatment: User-Centered Design Process.

Smartphone App to Self-Monitor Nausea During Pediatric Chemotherapy Treatment: User-Centered Design Process.

Journal: JMIR mHealth and uHealth

Published: March 05, 2020

Pharmacogenetics of antiemetics for chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis.

Pharmacogenetics of antiemetics for chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis.

Journal: Critical reviews in oncology/hematology

Published: October 27, 2019

Real-world effectiveness and safety of pharmacological thromboprophylaxis in patients undergoing primary total hip and knee arthroplasty: A narrative review.

Real-world effectiveness and safety of pharmacological thromboprophylaxis in patients undergoing primary total hip and knee arthroplasty: A narrative review.

Journal: Journal of orthopaedics

Published: October 14, 2019

Insufficient evidence in prophylactic therapy of chemotherapy-induced nausea and vomiting in children and adolescents

Insufficient evidence in prophylactic therapy of chemotherapy-induced nausea and vomiting in children and adolescents

Journal: Ugeskrift for laeger

Published: August 29, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026